Wed-02-09-2015, 12:24 PM
(Wed-02-09-2015, 11:25 AM)jiml Wrote: I for one am glad they have pushed ahead with this drug it has proved to be very effective and an additional tool for dermatologists. I think the fear of suicidal thoughts being associated with it may put some patients off trying it, but I'm sure the dermatologists that prescribe it will be fully aware of the side effects and will hopefully monitor the recipient closely.
I hope they get approval when the drug is submitted both in the U.S. And Europe
Yes I think it's a good thing to keep the trials going, they will obviously be vigilant and keep an eye on things. Suicidal thoughts is a very serious side effect, but with close monitoring and appraisal of the patient this could be a good treatment for a lot of people.
Unfortunately Amgen felt it was to much of a risk, whether that was do to safety or shareholders we will never know. But my thoughts would be shareholders come first, would they invest in something that could cause suicidal thoughts.
At least Valeant have the guts to give it a go.